Patient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials

Authors:
  • JSJesús San-Miguel
    Jesús San-Miguel
  • SUSaad Usmani
    Saad Usmani
  • SZSonja Zweegman
    Sonja Zweegman
  • PMPhilippe Moreau
    Philippe Moreau
  • MBMario Boccadoro
    Mario Boccadoro
  • MDMeletios Dimopoulos
    Meletios Dimopoulos
  • HEHermann Einsele
    Hermann Einsele
  • PRPaula Rodríguez-Otero
    Paula Rodríguez-Otero
  • TFThierry Facon
    Thierry Facon
  • JBJ. Blake Bartlett
    J. Blake Bartlett
  • TPThomas Prior
    Thomas Prior
  • KGKatharine Gries
    Katharine Gries

Abstract
No abstract available